Skip to Content

Verano Holdings Corp Ordinary Shares - Class A (Sub Voting) VRNOF

Morningstar Rating
$4.93 +0.23 (4.92%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VRNOF is trading at a 35% discount.
Price
$4.83
Fair Value
$3.59
Uncertainty
Very High
1-Star Price
$57.38
5-Star Price
$5.27
Economic Moat
Nynx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VRNOF is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$4.70
Day Range
$4.665.18
52-Week Range
$2.537.08
Bid/Ask
$4.85 / $5.05
Market Cap
$1.70 Bil
Volume/Avg
157,562 / 375,256

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.72
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Verano Holdings Corp is a vertically integrated multi‐state cannabis operator in the United States. The Company has two reportable segments: (i) cultivation (wholesale) and (ii) retail. The company's consumer brands include Encore, Avexia, MÜV, Savvy, BITS and Verano. The company's retail dispensaries operate under brands including Zen Leaf and MÜV. The company derives its revenues from Retail segment.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
3,780

Comparables

Valuation

Metric
VRNOF
CL
GLAS.A.U
Price/Earnings (Normalized)
Price/Book Value
1.301.436.90
Price/Sales
1.720.883.91
Price/Cash Flow
14.6615.6067.14
Price/Earnings
VRNOF
CL
GLAS.A.U

Financial Strength

Metric
VRNOF
CL
GLAS.A.U
Quick Ratio
0.520.780.38
Current Ratio
0.961.390.56
Interest Coverage
1.46−1.36−7.98
Quick Ratio
VRNOF
CL
GLAS.A.U

Profitability

Metric
VRNOF
CL
GLAS.A.U
Return on Assets (Normalized)
−2.28%−3.12%−7.05%
Return on Equity (Normalized)
−4.10%−8.02%−18.87%
Return on Invested Capital (Normalized)
−0.53%−0.11%−6.36%
Return on Assets
VRNOF
CL
GLAS.A.U
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AVhwjzspqyRrf$72.4 Bil
MKKGY
Merck KGaA ADRZrsfrcycgDgkkyr$70.8 Bil
HLN
Haleon PLC ADRWkxqfbfhBjc$38.2 Bil
VTRS
Viatris IncXxxnbpwqKrlkw$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRTmsldqdcfRgfkk$12.5 Bil
CTLT
Catalent IncKcxmzsgTtpcqq$10.1 Bil
PRGO
Perrigo Co PLCFjkrxglfJpzr$4.3 Bil
CURLF
Curaleaf Holdings IncSgqcnvdCdtl$3.7 Bil
PBH
Prestige Consumer Healthcare IncBjqfmwrqMdpxdbq$3.5 Bil
GTBIF
Green Thumb Industries IncWhmprfrjcPyzbb$2.9 Bil

Sponsor Center